Search research articles
Contact Us
Filters
Showing results (11-20 of 34) with videos related to
Page
of 4
Sort By:
Plos Biology
|
March 19, 2026
Pathogen host jump risk is not predicted by spillover rate, but rather by novelty
Brandon J Simony, David A Kennedy
Plos Biology
|
August 21, 2025
Early epidemiological characteristics explain the chance of population-level virus persistence following spillover events
Clara L Shaw, David A Kennedy
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Spillover rate is not a predictor of host jump risk, but spillover novelty is
Brandon J Simony, David A Kennedy
Proceedings. Biological Sciences
|
March 31, 2017
Why does drug resistance readily evolve but vaccine resistance does not?
David A Kennedy, Andrew F Read
Medrxiv : the Preprint Server for Health Sciences
|
May 19, 2025
Heterogeneity in and correlation between host transmissibility and susceptibility can greatly impact epidemic dynamics
Beth M Tuschhoff, David A Kennedy
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2018
Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance
David A Kennedy, Andrew F Read
The American Naturalist
|
August 21, 2014
Pathogen growth in insect hosts: inferring the importance of different mechanisms using stochastic models and response-time data
David A Kennedy, Vanja Dukic, Greg Dwyer
Evolution Letters
|
August 5, 2024
Exceptions to the rule: When does resistance evolution not undermine antibiotic therapy in human bacterial infections?
Amrita Bhattacharya, Anton Aluquin, David A Kennedy
Epidemics
|
January 26, 2018
Modeling Marek's disease virus transmission: A framework for evaluating the impact of farming practices and evolution
David A Kennedy, Patricia A Dunn, Andrew F Read
Plos Biology
|
November 16, 2021
The economics of managing evolution
Troy Day, David A Kennedy, Andrew F Read, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 34) with videos related to
Sort By:
Page
of 4
Plos Biology
|
March 19, 2026
Pathogen host jump risk is not predicted by spillover rate, but rather by novelty
Brandon J Simony, David A Kennedy
Plos Biology
|
August 21, 2025
Early epidemiological characteristics explain the chance of population-level virus persistence following spillover events
Clara L Shaw, David A Kennedy
Biorxiv : the Preprint Server for Biology
|
June 12, 2025
Spillover rate is not a predictor of host jump risk, but spillover novelty is
Brandon J Simony, David A Kennedy
Proceedings. Biological Sciences
|
March 31, 2017
Why does drug resistance readily evolve but vaccine resistance does not?
David A Kennedy, Andrew F Read
Medrxiv : the Preprint Server for Health Sciences
|
May 19, 2025
Heterogeneity in and correlation between host transmissibility and susceptibility can greatly impact epidemic dynamics
Beth M Tuschhoff, David A Kennedy
Proceedings of the National Academy of Sciences of the United States of America
|
December 19, 2018
Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance
David A Kennedy, Andrew F Read
The American Naturalist
|
August 21, 2014
Pathogen growth in insect hosts: inferring the importance of different mechanisms using stochastic models and response-time data
David A Kennedy, Vanja Dukic, Greg Dwyer
Evolution Letters
|
August 5, 2024
Exceptions to the rule: When does resistance evolution not undermine antibiotic therapy in human bacterial infections?
Amrita Bhattacharya, Anton Aluquin, David A Kennedy
Epidemics
|
January 26, 2018
Modeling Marek's disease virus transmission: A framework for evaluating the impact of farming practices and evolution
David A Kennedy, Patricia A Dunn, Andrew F Read
Plos Biology
|
November 16, 2021
The economics of managing evolution
Troy Day, David A Kennedy, Andrew F Read, et al.
Page
of 4